RFL

Rafael (RFL)

Rafael Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:RFL

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	22 : 00	Business Wire	Cyclo Therapeutics Achieves Landmark Milestone with Completion of Enrollment of Last Patient in Phase 3 Pivotal TransportNPC™ Trial of Niemann-Pick Type C1	NYSE:RFL	Rafael Holdings Inc
2024/05/23	21 : 15	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NYSE:RFL	Rafael Holdings Inc
2024/03/14	06 : 04	GlobeNewswire Inc.	Rafael Holdings Reports Second Quarter Fiscal 2024 Financial Results	NYSE:RFL	Rafael Holdings Inc
2024/01/18	23 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2024/01/16	21 : 50	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RFL	Rafael Holdings Inc
2024/01/13	05 : 23	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2024/01/13	05 : 13	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2023/12/27	04 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2023/12/27	04 : 23	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2023/12/15	06 : 36	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:RFL	Rafael Holdings Inc
2023/12/15	06 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RFL	Rafael Holdings Inc
2023/12/15	06 : 01	GlobeNewswire Inc.	Rafael Holdings Reports First Quarter Fiscal 2024 Financial Results	NYSE:RFL	Rafael Holdings Inc
2023/11/21	07 : 05	Edgar (US Regulatory)	Form DEFR14A - Revised definitive proxy soliciting materials	NYSE:RFL	Rafael Holdings Inc
2023/11/21	05 : 59	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NYSE:RFL	Rafael Holdings Inc
2023/11/15	22 : 05	Business Wire	Cyclo Therapeutics Reports Third Quarter 2023 Financial Results	NYSE:RFL	Rafael Holdings Inc
2023/10/31	06 : 18	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:RFL	Rafael Holdings Inc
2023/10/31	05 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RFL	Rafael Holdings Inc
2023/10/31	05 : 01	GlobeNewswire Inc.	Rafael Holdings Reports Fourth Quarter and Full Year Fiscal 2023 Financial Results	NYSE:RFL	Rafael Holdings Inc
2023/10/27	05 : 37	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RFL	Rafael Holdings Inc
2023/10/27	05 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2023/10/27	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2023/09/27	04 : 59	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2023/09/22	22 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:RFL	Rafael Holdings Inc
2023/08/30	05 : 31	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:RFL	Rafael Holdings Inc
2023/08/15	21 : 05	Business Wire	Cyclo Therapeutics Reports Second Quarter 2023 Financial Results	NYSE:RFL	Rafael Holdings Inc
2023/08/10	06 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RFL	Rafael Holdings Inc
2023/08/03	05 : 51	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NYSE:RFL	Rafael Holdings Inc
2023/08/02	21 : 34	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:RFL	Rafael Holdings Inc
2023/08/02	21 : 16	Business Wire	Cyclo Therapeutics Announces Closing of $5.0 Million Private Placement with Rafael Holdings, Inc.	NYSE:RFL	Rafael Holdings Inc
2023/06/23	02 : 22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NYSE:RFL	Rafael Holdings Inc